Organon & Co | OGN - Capitalisation Boursière





Capitalisation Boursière Changement Date
Bristol-Myers Squibb USD 122.54B 1.29B 2026-04
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.78B 215M 2025-12
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
Gilead Sciences USD 166.62B 14.34B 2026-04
Glaxosmithkline GBP 99.93B 13.05B 2025-12
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Merck USD 279.96B 18.7B 2026-04
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Novartis USD 263.08B 17.01B 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Organon & Co USD 3.41B 1.55B 2026-04
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pharma Mar EUR 1.68B 330.24M 2026-04
Qiagen NV USD 6.8B 1.47B 2026-04
Sartorius EUR 7.48B 6.76B 2026-04
Zealand Pharma A/S 33.35B 0 2026-04